Stroke Management Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027
The global stroke management market reached a value of US$ 31.1 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 46.8 Billion by 2027, exhibiting a CAGR of 6.97% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
A stroke occurs when a blockage or bleeding in blood vessels prevents an adequate supply of oxygen and nutrients to the brain. Its effective management assists in reducing brain damage and other complications. Stroke management involves a complete initial evaluation and assessment of patients with acute stroke using an echocardiogram, carotid ultrasound, cerebral angiogram, blood tests, computerized tomography (CT) scan, and magnetic resonance imaging (MRI). As per the evaluation and assessment results and patient's condition, treatment options for stroke like intravenous (IV) medication, endovascular procedures, intubation, and surgeries are opted by physicians.
Stroke Management Market Trends:
Chronic diseases, including hypertension, migraine, diabetes, dyslipidemia, obesity, cardiac diseases, atrial fibrillation, sickle cell, atrial fibrillation, carotid stenosis, and obstructive sleep apnea, are among the leading factors elevating the risk of stroke. This, in confluence with the increasing prevalence of these diseases among a significant part of the population, represents one of the primary factors escalating the need for stroke management across the globe. Additionally, physical inactivity, tobacco use, unhealthy diet and nutrition, and excessive drug and alcohol consumption are other factors influencing the market positively. Apart from this, due to the increasing geriatric population, which is more vulnerable to stroke, there is a rise in the demand for efficient stroke management. Furthermore, governing bodies of numerous countries are launching public health programs that encourage people to have periodic screening examinations for detecting chronic diseases. This, in confluence with the rising awareness among individuals about the advantages of early diagnosis and treatment, is leading to market growth. The approval of new and advanced devices and drugs is also creating a favorable outlook for the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global stroke management market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on type, application and end user.
Breakup by Type:
Diagnostics
Computed Tomography Scan (CT Scan)
Magnetic Resonance Imaging (MRI)
Carotid Ultrasound
Cerebral Angiography
Electrocardiography
Echocardiography
Others
Therapeutics
Tissue Plasminogen Activator
Anticoagulant
Antiplatelet
Antihypertensive
Breakup by Application:
Ischemic Stroke
Haemorrhagic Stroke
Others
Breakup by End User:
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, B. Braun Melsungen AG, Boston Scientific Corporation, Bristol-Myers Squibb Company, Cardinal Health, General Electric Company, GlaxoSmithKline plc, Medtronic plc, Merck & Co. Inc. and Siemens Healthineers AG (Siemens AG).
Key Questions Answered in This Report:
How has the global stroke management market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global stroke management market?
What are the key regional markets?
What is the breakup of the market based on the type?
What is the breakup of the market based on the application?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global stroke management market and who are the key players?
What is the degree of competition in the industry?
A stroke occurs when a blockage or bleeding in blood vessels prevents an adequate supply of oxygen and nutrients to the brain. Its effective management assists in reducing brain damage and other complications. Stroke management involves a complete initial evaluation and assessment of patients with acute stroke using an echocardiogram, carotid ultrasound, cerebral angiogram, blood tests, computerized tomography (CT) scan, and magnetic resonance imaging (MRI). As per the evaluation and assessment results and patient's condition, treatment options for stroke like intravenous (IV) medication, endovascular procedures, intubation, and surgeries are opted by physicians.
Stroke Management Market Trends:
Chronic diseases, including hypertension, migraine, diabetes, dyslipidemia, obesity, cardiac diseases, atrial fibrillation, sickle cell, atrial fibrillation, carotid stenosis, and obstructive sleep apnea, are among the leading factors elevating the risk of stroke. This, in confluence with the increasing prevalence of these diseases among a significant part of the population, represents one of the primary factors escalating the need for stroke management across the globe. Additionally, physical inactivity, tobacco use, unhealthy diet and nutrition, and excessive drug and alcohol consumption are other factors influencing the market positively. Apart from this, due to the increasing geriatric population, which is more vulnerable to stroke, there is a rise in the demand for efficient stroke management. Furthermore, governing bodies of numerous countries are launching public health programs that encourage people to have periodic screening examinations for detecting chronic diseases. This, in confluence with the rising awareness among individuals about the advantages of early diagnosis and treatment, is leading to market growth. The approval of new and advanced devices and drugs is also creating a favorable outlook for the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global stroke management market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on type, application and end user.
Breakup by Type:
Diagnostics
Computed Tomography Scan (CT Scan)
Magnetic Resonance Imaging (MRI)
Carotid Ultrasound
Cerebral Angiography
Electrocardiography
Echocardiography
Others
Therapeutics
Tissue Plasminogen Activator
Anticoagulant
Antiplatelet
Antihypertensive
Breakup by Application:
Ischemic Stroke
Haemorrhagic Stroke
Others
Breakup by End User:
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, B. Braun Melsungen AG, Boston Scientific Corporation, Bristol-Myers Squibb Company, Cardinal Health, General Electric Company, GlaxoSmithKline plc, Medtronic plc, Merck & Co. Inc. and Siemens Healthineers AG (Siemens AG).
Key Questions Answered in This Report:
How has the global stroke management market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global stroke management market?
What are the key regional markets?
What is the breakup of the market based on the type?
What is the breakup of the market based on the application?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global stroke management market and who are the key players?
What is the degree of competition in the industry?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL STROKE MANAGEMENT MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY TYPE
6.1 Diagnostics
6.1.1 Market Trends
6.1.2 Key Segments
6.1.2.1 Computed Tomography Scan (CT Scan)
6.1.2.2 Magnetic Resonance Imaging (MRI)
6.1.2.3 Carotid Ultrasound
6.1.2.4 Cerebral Angiography
6.1.2.5 Electrocardiography
6.1.2.6 Echocardiography
6.1.2.7 Others
6.1.3 Market Forecast
6.2 Therapeutics
6.2.1 Market Trends
6.2.2 Key Segments
6.2.2.1 Tissue Plasminogen Activator
6.2.2.2 Anticoagulant
6.2.2.3 Antiplatelet
6.2.2.4 Antihypertensive
6.2.3 Market Forecast
7 MARKET BREAKUP BY APPLICATION
7.1 Ischemic Stroke
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Haemorrhagic Stroke
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Others
7.3.1 Market Trends
7.3.2 Market Forecast
8 MARKET BREAKUP BY END USER
8.1 Hospitals
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Ambulatory Surgical Centers
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Diagnostic Centers
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 MARKET BREAKUP BY REGION
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT ANALYSIS
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 VALUE CHAIN ANALYSIS
12 PORTERS FIVE FORCES ANALYSIS
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 PRICE ANALYSIS
14 COMPETITIVE LANDSCAPE
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Abbott Laboratories
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 B. Braun Melsungen AG
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 SWOT Analysis
14.3.3 Boston Scientific Corporation
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Bristol-Myers Squibb Company
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 Cardinal Health
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 General Electric Company
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 GlaxoSmithKline plc
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 Medtronic plc
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Merck & Co. Inc.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 Siemens Healthineers AG (Siemens AG)
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL STROKE MANAGEMENT MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY TYPE
6.1 Diagnostics
6.1.1 Market Trends
6.1.2 Key Segments
6.1.2.1 Computed Tomography Scan (CT Scan)
6.1.2.2 Magnetic Resonance Imaging (MRI)
6.1.2.3 Carotid Ultrasound
6.1.2.4 Cerebral Angiography
6.1.2.5 Electrocardiography
6.1.2.6 Echocardiography
6.1.2.7 Others
6.1.3 Market Forecast
6.2 Therapeutics
6.2.1 Market Trends
6.2.2 Key Segments
6.2.2.1 Tissue Plasminogen Activator
6.2.2.2 Anticoagulant
6.2.2.3 Antiplatelet
6.2.2.4 Antihypertensive
6.2.3 Market Forecast
7 MARKET BREAKUP BY APPLICATION
7.1 Ischemic Stroke
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Haemorrhagic Stroke
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Others
7.3.1 Market Trends
7.3.2 Market Forecast
8 MARKET BREAKUP BY END USER
8.1 Hospitals
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Ambulatory Surgical Centers
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Diagnostic Centers
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 MARKET BREAKUP BY REGION
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT ANALYSIS
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 VALUE CHAIN ANALYSIS
12 PORTERS FIVE FORCES ANALYSIS
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 PRICE ANALYSIS
14 COMPETITIVE LANDSCAPE
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Abbott Laboratories
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 B. Braun Melsungen AG
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 SWOT Analysis
14.3.3 Boston Scientific Corporation
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Bristol-Myers Squibb Company
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 Cardinal Health
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 General Electric Company
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 GlaxoSmithKline plc
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 Medtronic plc
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Merck & Co. Inc.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 Siemens Healthineers AG (Siemens AG)
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
LIST OF TABLES
Table 1: Global: Stroke Management Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Stroke Management Market Forecast: Breakup by Type (in Million US$), 2022-2027
Table 3: Global: Stroke Management Market Forecast: Breakup by Application (in Million US$), 2022-2027
Table 4: Global: Stroke Management Market Forecast: Breakup by End User (in Million US$), 2022-2027
Table 5: Global: Stroke Management Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 6: Global: Stroke Management Market: Competitive Structure
Table 7: Global: Stroke Management Market: Key Players
Table 1: Global: Stroke Management Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Stroke Management Market Forecast: Breakup by Type (in Million US$), 2022-2027
Table 3: Global: Stroke Management Market Forecast: Breakup by Application (in Million US$), 2022-2027
Table 4: Global: Stroke Management Market Forecast: Breakup by End User (in Million US$), 2022-2027
Table 5: Global: Stroke Management Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 6: Global: Stroke Management Market: Competitive Structure
Table 7: Global: Stroke Management Market: Key Players
LIST OF FIGURES
Figure 1: Global: Stroke Management Market: Major Drivers and Challenges
Figure 2: Global: Stroke Management Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Stroke Management Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Stroke Management Market: Breakup by Type (in %), 2021
Figure 5: Global: Stroke Management Market: Breakup by Application (in %), 2021
Figure 6: Global: Stroke Management Market: Breakup by End User (in %), 2021
Figure 7: Global: Stroke Management Market: Breakup by Region (in %), 2021
Figure 8: Global: Stroke Management (Diagnostics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: Stroke Management (Diagnostics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: Stroke Management (Therapeutics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Stroke Management (Therapeutics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Stroke Management (Ischemic Stroke) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Stroke Management (Ischemic Stroke) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Stroke Management (Haemorrhagic Stroke) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Stroke Management (Haemorrhagic Stroke) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Stroke Management (Other Applications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Stroke Management (Other Applications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Stroke Management (Hospitals) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Stroke Management (Hospitals) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Stroke Management (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Stroke Management (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Stroke Management (Diagnostic Centers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Stroke Management (Diagnostic Centers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Stroke Management (Other End Users) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Stroke Management (Other End Users) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: North America: Stroke Management Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: North America: Stroke Management Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: United States: Stroke Management Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: United States: Stroke Management Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: Canada: Stroke Management Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: Canada: Stroke Management Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: Asia-Pacific: Stroke Management Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: Asia-Pacific: Stroke Management Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: China: Stroke Management Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: China: Stroke Management Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: Japan: Stroke Management Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: Japan: Stroke Management Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: India: Stroke Management Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: India: Stroke Management Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: South Korea: Stroke Management Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: South Korea: Stroke Management Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: Australia: Stroke Management Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: Australia: Stroke Management Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: Indonesia: Stroke Management Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: Indonesia: Stroke Management Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Others: Stroke Management Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Others: Stroke Management Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: Europe: Stroke Management Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: Europe: Stroke Management Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: Germany: Stroke Management Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: Germany: Stroke Management Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: France: Stroke Management Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: France: Stroke Management Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: United Kingdom: Stroke Management Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: United Kingdom: Stroke Management Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: Italy: Stroke Management Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: Italy: Stroke Management Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: Spain: Stroke Management Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: Spain: Stroke Management Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Russia: Stroke Management Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Russia: Stroke Management Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Others: Stroke Management Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Others: Stroke Management Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Latin America: Stroke Management Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Latin America: Stroke Management Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Brazil: Stroke Management Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Brazil: Stroke Management Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Mexico: Stroke Management Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Mexico: Stroke Management Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Others: Stroke Management Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Others: Stroke Management Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Middle East and Africa: Stroke Management Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Middle East and Africa: Stroke Management Market: Breakup by Country (in %), 2021
Figure 74: Middle East and Africa: Stroke Management Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 75: Global: Stroke Management Industry: SWOT Analysis
Figure 76: Global: Stroke Management Industry: Value Chain Analysis
Figure 77: Global: Stroke Management Industry: Porter's Five Forces Analysis
Figure 1: Global: Stroke Management Market: Major Drivers and Challenges
Figure 2: Global: Stroke Management Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Stroke Management Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Stroke Management Market: Breakup by Type (in %), 2021
Figure 5: Global: Stroke Management Market: Breakup by Application (in %), 2021
Figure 6: Global: Stroke Management Market: Breakup by End User (in %), 2021
Figure 7: Global: Stroke Management Market: Breakup by Region (in %), 2021
Figure 8: Global: Stroke Management (Diagnostics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: Stroke Management (Diagnostics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: Stroke Management (Therapeutics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Stroke Management (Therapeutics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Stroke Management (Ischemic Stroke) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Stroke Management (Ischemic Stroke) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Stroke Management (Haemorrhagic Stroke) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Stroke Management (Haemorrhagic Stroke) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Stroke Management (Other Applications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Stroke Management (Other Applications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Stroke Management (Hospitals) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Stroke Management (Hospitals) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Stroke Management (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Stroke Management (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Stroke Management (Diagnostic Centers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Stroke Management (Diagnostic Centers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Stroke Management (Other End Users) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Stroke Management (Other End Users) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: North America: Stroke Management Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: North America: Stroke Management Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: United States: Stroke Management Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: United States: Stroke Management Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: Canada: Stroke Management Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: Canada: Stroke Management Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: Asia-Pacific: Stroke Management Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: Asia-Pacific: Stroke Management Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: China: Stroke Management Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: China: Stroke Management Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: Japan: Stroke Management Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: Japan: Stroke Management Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: India: Stroke Management Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: India: Stroke Management Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: South Korea: Stroke Management Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: South Korea: Stroke Management Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: Australia: Stroke Management Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: Australia: Stroke Management Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: Indonesia: Stroke Management Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: Indonesia: Stroke Management Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Others: Stroke Management Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Others: Stroke Management Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: Europe: Stroke Management Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: Europe: Stroke Management Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: Germany: Stroke Management Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: Germany: Stroke Management Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: France: Stroke Management Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: France: Stroke Management Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: United Kingdom: Stroke Management Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: United Kingdom: Stroke Management Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: Italy: Stroke Management Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: Italy: Stroke Management Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: Spain: Stroke Management Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: Spain: Stroke Management Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Russia: Stroke Management Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Russia: Stroke Management Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Others: Stroke Management Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Others: Stroke Management Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Latin America: Stroke Management Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Latin America: Stroke Management Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Brazil: Stroke Management Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Brazil: Stroke Management Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Mexico: Stroke Management Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Mexico: Stroke Management Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Others: Stroke Management Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Others: Stroke Management Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Middle East and Africa: Stroke Management Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Middle East and Africa: Stroke Management Market: Breakup by Country (in %), 2021
Figure 74: Middle East and Africa: Stroke Management Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 75: Global: Stroke Management Industry: SWOT Analysis
Figure 76: Global: Stroke Management Industry: Value Chain Analysis
Figure 77: Global: Stroke Management Industry: Porter's Five Forces Analysis
